A molecular glue RBM39-degrader induces synthetic lethality in cancer cells with homologous recombination repair deficiency
Shinji Kohsaka(National Cancer Research Institute), Hiroyuki Mano(National Cancer Research Institute)
Cited by 14
Related Papers
STAT3 Inhibition Overcomes Temozolomide Resistance in Glioblastoma by Downregulating MGMT Expression
|Molecular Cancer Therapeutics|2012|196
Uterine adenomyosis is an oligoclonal disorder associated with KRAS mutations
|Nature Communications|2019|137
High-throughput functional evaluation of BRCA2 variants of unknown significance
|Nature Communications|2020|64
Comprehensive functional evaluation of variants of fibroblast growth factor receptor genes in cancer
|npj Precision Oncology|2021|53